Anders PEDERSEN
7Patents
2h-index
10Co-inventors
44Inventor score
Filing activity: Jun 4, 2008 → May 13, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8821928B2 | Controlled release pharmaceutical compositions for prolonged effect | Human Necessities | 14 | Active |
| US9642809B2 | Controlled release pharmaceutical compositions for prolonged effect | Human Necessities | 6 | Active |
| US10307403B2 | Polymorphic forms and process | Chemistry; Metallurgy | 0 | Active |
| US10799482B2 | Polymorphic forms and process | Chemistry; Metallurgy | 0 | Active |
| US10369136B2 | Polymorphic forms and process | Chemistry; Metallurgy | 0 | Active |
| US11406655B2 | Once-daily treatment of pulmonary fibrosis | Human Necessities | 0 | Active |
| US10730902B2 | 1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.